Company
EpimAb Biotherapeutics
Advancing Bispecifics to the Next Stage
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Shanghai, China
- Founded
- 2015
Claim, correct or request removal
Record updated 28 September 2026
About
EpimAb Biotherapeutics is a clinical stage biopharmaceutical company with research facilities in Shanghai. With our unique and proprietary platform technology called FIT-Ig® (Fabs-In-Tandem Immunoglobulin) that is able to generate bispecific molecules with antibody-like properties, we are creating a pipeline of novel therapeutics focused around immuno-oncology and other disease areas with high unmet need.
Loading relationship preview